Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in high-risk coronary artery disease
NCT02874287Phase 4Completed
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Oct 2017
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxychloroquine in coronary artery disease (CAD), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Started Oct 2017; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02874287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02874287.